.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,536,241

« Back to Dashboard

Details for Patent: 5,536,241

Title: Methods and devices for relaxing smooth muscle contractions
Abstract:Methods and devices for using nitric oxide (NO) to decrease or prevent the contraction of a smooth muscle in a non-respiratory-tract organ of an animal, the organ being one which contains or is surrounded by a biological fluid which is not blood, which method includes the step of introducing an effective amount of NO into the fluid.
Inventor(s): Zapol; Warren M. (Concord, MA)
Assignee: The General Hospital Corporation (Boston, MA)
Filing Date:Mar 24, 1993
Application Number:08/036,522
Claims:1. A device for relaxing smooth muscle of a hollow organ, the organ being a non-respiratory tract organ containing a non-blood biological fluid, said device comprising

a source of nitric oxide (NO); and

a section of gas-permeable material having a first and a second face, said first face being configured to be placed in contact with the fluid and said second face being in communication with said source of NO, said section separating the fluid from said source of NO, wherein NO can diffuse through the material from said second face to said first face.

2. The device of claim 1, wherein said NO is in gaseous form, and said device additionally comprises a mechanism for controllably releasing said NO to contact said second face.

3. The device of claim 1, wherein said section of gas-permeable material is configured to be implanted in the organ, with said first face in contact with the fluid within the organ.

4. The device of claim 3, wherein said NO is in gaseous form, and said device additionally comprises a mechanism for controllably releasing said NO to contact said second face.

5. The device of claim 3, wherein NO.sub.2 is substantially absent from said source of NO.

6. The device of claim 3, wherein O.sub.2 is substantially absent from said source of NO.

7. The device of claim 3, wherein said source of NO is a liquid in which gaseous NO is dissolved.

8. The device of claim 3, wherein said source of NO is an aqueous solution of an NO-releasing compound.

9. The device of claim 1, wherein said first face is in communication with the lumen of a tube through which the fluid can be drawn out of the organ and into contact with said first face, said device further comprising a mechanism for accomplishing said drawing.

10. The device of claim 9, wherein said device further comprises a mechanism for returning the fluid to the organ through said tube after the fluid has contacted said first face.

11. The device of claim 9, wherein said device further comprises a second tube through which the fluid is returned to the organ after the fluid has contacted said first face.

12. The device of claim 9, wherein said NO is in gaseous form, and said device additionally comprises a mechanism for controllably releasing said NO to contact said second face.

13. The device of claim 9, wherein NO.sub.2 is substantially absent from said source of NO.

14. The device of claim 9, wherein O.sub.2 is substantially absent from said source of NO.

15. The device of claim 9, wherein said source of NO is a liquid in which gaseous NO is dissolved.

16. The device of claim 9, wherein said source of NO is an aqueous solution of an NO-releasing compound.

17. The device of claim 1, wherein nitrogen dioxide (NO.sub.2) is substantially absent from said source of NO.

18. The device of claim 1, wherein oxygen (O.sub.2) is substantially absent from said source of NO.

19. A device for relaxing smooth muscle in an organ, the organ being a non-respiratory tract organ containing a non-blood biological fluid, said device comprising

a housing defining a chamber; and

an NO-releasing compound contained within said chamber, said chamber having a wall comprising solute-permeable material through which said NO-releasing compound can diffuse, said wall being configured to be placed in contact with the biological fluid.

20. The device of claim 19, wherein said NO-releasing compound is selected from the group consisting of S-nitroso-N-acetylpenicillamine, S-nitrosocysteine, nitroprusside, nitrosoguanidine, Na(O.sub.2 N.sub.2 --NEt.sub.2), nitroglycerine, isoamyl nitrite, inorganic nitrite, azide, and hydroxylamine.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc